Home

Clarus Ventures II GP, L.P.

CIK 1431439 · last filed 2017-10-13

Clarus Ventures II GP, L.P. is a corporate insider who has filed 10 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for HAIR, was dated Oct 13, 2017. Across all open-market trades the lifetime net is −$59.6M, making them a net seller over the disclosed history. The firm reports its address in Cambridge, MA. 44 SEC filings were submitted jointly with Clarus Lifesciences II, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

10

Lifetime Open-Market Net

-$59.56M

Filer Profile

Reported Address
101 MAIN STREET
SUITE 1210
CAMBRIDGE, MA 02142
Phone
(617) 949-2200
State of Incorporation
DE
Related Filers
Clarus Lifesciences II, L.P. — 44 joint filings, latest 2019-03-22
Clarus Ventures II, LLC — 43 joint filings, latest 2018-09-19
NICHOLAS GALAKATOS — 32 joint filings, latest 2017-10-17
DENNIS HENNER — 32 joint filings, latest 2017-10-17
ROBERT LIPTAK — 32 joint filings, latest 2017-10-17
KURT WHEELER — 32 joint filings, latest 2017-10-17
Nicholas Simon — 31 joint filings, latest 2017-10-17
MICHAEL STEINMETZ — 29 joint filings, latest 2016-02-10
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Venus Concept Inc. (HAIR) Delisted 10%+ Owner — — — $0 1 2017-10-13
NanoString Technologies Inc (NSTG) Delisted 10%+ Owner — $0.11 — $0 3 2017-01-04
AERIE PHARMACEUTICALS INC (AERI) Delisted 10%+ Owner 0 $15.25 $0 -$49.00M 2 2015-01-30
ACHILLION PHARMACEUTICALS INC (ACHN) Delisted 10%+ Owner 3 — — -$10.67M 3 2012-06-06
ACHILLION PHARMACEUTICALS INC (TPTX) Delisted 10%+ Owner 312,107 $76.01 $23.72M $104.8K 1 2008-09-09

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-10-13 Venus Concept Inc. (HAIR) Delisted Other (J) — $0 EDGAR
2017-01-04 NanoString Technologies Inc (NSTG) Delisted Grant (A) — $0 EDGAR
2015-01-30 AERIE PHARMACEUTICALS INC (AERI) Delisted Other (J) −28,255,023 $0 EDGAR
2015-01-12 AERIE PHARMACEUTICALS INC (AERI) Delisted Sell (S) −1,575,000 -$49.00M EDGAR
2014-01-03 NanoString Technologies Inc (NSTG) Delisted Grant (A) — $0 EDGAR
2013-07-12 NanoString Technologies Inc (NSTG) Delisted Grant (A) — $0 EDGAR
2012-06-06 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Other (J) −87,539,744 $0 EDGAR
2010-01-13 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Sell (S) −2,339,900 -$8.81M EDGAR
2010-01-08 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Sell (S) −530,000 -$1.86M EDGAR
2008-09-09 ACHILLION PHARMACEUTICALS INC (TPTX) Delisted Buy (P) +46,540 $104.8K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.